Inhibitory effect of ciprofloxacin on β‐glucuronidase‐mediated deconjugation of mycophenolic acid glucuronide. (20th March 2014)
- Record Type:
- Journal Article
- Title:
- Inhibitory effect of ciprofloxacin on β‐glucuronidase‐mediated deconjugation of mycophenolic acid glucuronide. (20th March 2014)
- Main Title:
- Inhibitory effect of ciprofloxacin on β‐glucuronidase‐mediated deconjugation of mycophenolic acid glucuronide
- Authors:
- Kodawara, Takaaki
Masuda, Satohiro
Yano, Yoshitaka
Matsubara, Kazuo
Nakamura, Toshiaki
Masada, Mikio - Abstract:
- <abstract abstract-type="main"> <title>ABSTRACT</title> <p>The interaction between mycophenolate (MPA) and quinolone antibiotics such as ciprofloxacin is considered to reduce the enterohepatic recycling of MPA, which is biotransformed in the intestine from MPA glucuronide (MPAG) conjugate excreted via the biliary system; however, the molecular mechanism underlying this biotransformation of MPA is still unclear. In this study, an <italic>in vitro</italic> system was established to evaluate β‐glucuronidase‐mediated deconjugation and to examine the influence of ciprofloxacin on the enzymatic deconjugation of MPAG and MPA resynthesis. Resynthesis of MPA via deconjugation of MPAG increased in a time‐dependent manner from 5 to 60 min in the presence of β‐glucuronidase. Ciprofloxacin and phenolphthalein‐β‐<sc>d</sc>‐glucuronide (PhePG), a typical β‐glucuronidase substrate, significantly decreased the production of MPA from MPAG in the β‐glucuronidase‐mediated deconjugation system. In addition, enoxacin significantly inhibited the production of MPA from MPAG, while levofloxacin and ofloxacin had no inhibitory effect on MPA synthesis. Pharmacokinetic analysis revealed that ciprofloxacin showed a dose‐dependent inhibitory effect on MPA production from MPAG via β‐glucuronidase with a half‐maximal inhibitory concentration (IC<sub>50</sub>) value of 30.4 µ<sc>m</sc>. While PhePG inhibited the β‐glucuronidase‐mediated production of MPA from MPAG in a competitive manner, ciprofloxacin<abstract abstract-type="main"> <title>ABSTRACT</title> <p>The interaction between mycophenolate (MPA) and quinolone antibiotics such as ciprofloxacin is considered to reduce the enterohepatic recycling of MPA, which is biotransformed in the intestine from MPA glucuronide (MPAG) conjugate excreted via the biliary system; however, the molecular mechanism underlying this biotransformation of MPA is still unclear. In this study, an <italic>in vitro</italic> system was established to evaluate β‐glucuronidase‐mediated deconjugation and to examine the influence of ciprofloxacin on the enzymatic deconjugation of MPAG and MPA resynthesis. Resynthesis of MPA via deconjugation of MPAG increased in a time‐dependent manner from 5 to 60 min in the presence of β‐glucuronidase. Ciprofloxacin and phenolphthalein‐β‐<sc>d</sc>‐glucuronide (PhePG), a typical β‐glucuronidase substrate, significantly decreased the production of MPA from MPAG in the β‐glucuronidase‐mediated deconjugation system. In addition, enoxacin significantly inhibited the production of MPA from MPAG, while levofloxacin and ofloxacin had no inhibitory effect on MPA synthesis. Pharmacokinetic analysis revealed that ciprofloxacin showed a dose‐dependent inhibitory effect on MPA production from MPAG via β‐glucuronidase with a half‐maximal inhibitory concentration (IC<sub>50</sub>) value of 30.4 µ<sc>m</sc>. While PhePG inhibited the β‐glucuronidase‐mediated production of MPA from MPAG in a competitive manner, ciprofloxacin inhibited MPA synthesis via noncompetitive inhibition. These findings suggest that the reduction in the serum MPA concentration during the co‐administration of ciprofloxacin is at least in part due to the decreased enterohepatic circulation of MPA because of noncompetitive inhibition of deconjugation of MPAG by intestinal β‐glucuronidase. Copyright © 2014 John Wiley &amp; Sons, Ltd.</p> </abstract> … (more)
- Is Part Of:
- Biopharmaceutics & drug disposition. Volume 35:Number 5(2014:Jul.)
- Journal:
- Biopharmaceutics & drug disposition
- Issue:
- Volume 35:Number 5(2014:Jul.)
- Issue Display:
- Volume 35, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 35
- Issue:
- 5
- Issue Sort Value:
- 2014-0035-0005-0000
- Page Start:
- 275
- Page End:
- 283
- Publication Date:
- 2014-03-20
- Subjects:
- Biopharmaceutics -- Periodicals
Drugs -- Metabolism -- Periodicals
Pharmacology -- Periodicals
Biopharmaceutics -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/bdd.1894 ↗
- Languages:
- English
- ISSNs:
- 0142-2782
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.355000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4146.xml